• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [15895 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2013 Penn Medicine Center for Evidence-based Practice (CEP) Obstetric early warning systems 
2013 Penn Medicine Center for Evidence-based Practice (CEP) Systematic reviews of robotic surgery in obstetrics and gynecology
2013 Penn Medicine Center for Evidence-based Practice (CEP) Specialized geriatric care for hospitalized inpatients
2013 Penn Medicine Center for Evidence-based Practice (CEP) Management of patients after the removal of an indwelling urinary catheter
2013 Penn Medicine Center for Evidence-based Practice (CEP) Nurse-directed protocols for removal of indwelling urinary catheters
2013 Penn Medicine Center for Evidence-based Practice (CEP) Central venous catheter removal
2013 Institut national d'excellence en sante et en services sociaux (INESSS) [Falls in patients living in health care facilities (short- and long-term care)]
2013 Institut national d'excellence en sante et en services sociaux (INESSS) [Self-monitoring of blood glucose in adult patients with Type 2 Diabetes not using insulin]
2013 Institut national d'excellence en sante et en services sociaux (INESSS) [Efficiency of short-term social and psychological therapies: Systematic review]
2013 Agenzia nazionale per i servizi sanitari regionali (Agenas) Implantable devices for the closure of patent foramen ovale (PFO) in adults. Rapid HTA report
2013 Health Council of the Netherlands Gezondheidsraad (GR) A closer look at Lyme disease
2013 Health Council of the Netherlands Gezondheidsraad (GR) The maximum number of children per sperm donor
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Somatropin (Genotropin - Pfizer Canada Inc.) indication: growth hormone deficiency in adults
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Dressings and care of skin graft sites: a review of clinical evidence and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal care of chronic, non-healing, lower extremity wounds: a review of clinical evidence and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Naloxone for use in long-term care and palliative care: clinical effectiveness, safety, and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Interventions for the prevention or management of childhood obesity: a review of the clinical evidence
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Transobturator slings for urinary incontinence: clinical effectiveness and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Removal of physical restraints in long term care settings: clinical safety and harm
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Computed tomography angiography versus computed tomography for the diagnosis and management of hyperacute stroke: a review of comparative clinical evidence and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Bioabsorbable stents for adults with coronary artery disease: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Diabetes screening for asymptomatic adults: a review of the diagnostic accuracy, cost effectiveness, and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Fluconazole administration for the treatment of ductal yeast enfections: clinical effectiveness and safety
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Nutritional supplementation for patients with cancer: clinical effectiveness and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Non-surgical debridement for chronic lower extremity wounds: clinical effectiveness and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Kidney transplantation following cardiocirculatory death: a review of the clinical evidence and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Lymphatic-Venous anastomosis for lymphedema: clinical and cost-effectiveness
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Prostate cancer screening: a review of the guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Pain management for pediatric patients in the emergency department: guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Bladder instillation of gentamicin for the treatment of recurrent urinary tract infections: clinical evidence and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Swabbing techniques for the detection of bacterial colonization in wounds: comparative clinical evidence and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Management of diabetes in the long-term care population: a review of guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Vaginal preparation prior to cesarean delivery: clinical evidence
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Azilsartan Medoxomil + Chlorthalidone (Edarbyclor- Takeda Canada Inc.) indication: severe hypertension
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Technologies assisting in remote consultations for the diagnosis of stroke: a review of the clinical evidence
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Appropriateness of CT imaging to support the diagnosis of stroke: a review of the clinical evidence
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Linagliptin-metformin (Jentadueto - Boehringer Ingelheim (Canada) Ltd.) indication: type 2 diabetes mellitus
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Perampanel (Fycompa - Eisai Ltd.) indication: epilepsy, partial-onset seizures
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Azilsartan Medoxomil (Edarbi - Takeda Canada Inc.) indication: mild to moderate essential hypertension
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Distance consultation for chronic, non-healing, lower extremity wounds: clinical evidence
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Plasma vaporization for the treatment of benign prostatic hypertrophy: clinical and cost-effectiveness, and safety
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Use of surgical masks in the operating room: a review of the clinical effectiveness and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Cleansing of the cervix prior to hysterosalpingogram: clinical evidence and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) CPAP treatment for adults with obstructive sleep apnea: review of the clinical and cost-effectiveness and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Dressing materials for the treatment of pressure ulcers in patients in long-term care facilities: a review of the comparative clinical effectiveness and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Suboxone versus methadone for the treatment of opioid dependence: a review of the clinical and cost-effectiveness
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Comparison of the Ankle Brachial Pressure Index (ABI) doppler with the pocket doppler with plethysmography probe in the assessment of arterial disease in diabetic patients: clinical and cost-effectiveness
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Medication administration via metered dose inhalers and aerochambers versus nebulizers for adult patients: clinical effectiveness
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Group care for chronic disease management: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Needle or open fasciotomy for dupuytren
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Medication assessment alerts for in-hospital medication management: clinical evidence and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Peer support for diabetes, heart disease and HIV/AIDS: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Pain neurophysiology education for the management of persistent pain: clinical evidence and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Negative pressure wound therapy for the management of high risk surgical incisions or high risk patients: clinical effectiveness, cost-effectiveness, and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Multi-dose contrast media for patients undergoing computed tomography: clinical benefits, harms, and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Follow-up imaging for simple adnexal cysts: clinical evidence, cost-effectiveness and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Ultrasound versus computed tomography for children with suspected appendicitis: clinical evidence, cost-effectiveness, and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Delivery of podiatry care for adults with diabetes or chronic foot conditions: a review of the clinical effectiveness
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) X-ray series for foot and ankle injuries: clinical evidence, cost-effectiveness, and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Adjuvant and neoadjuvant chemotherapy and radiation for the treatment of rectal cancer: economic evidence
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal screening procedures prior to physician visits: guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Anaphylaxis in seniors eeceiving intravenous antibiotics in long-term care: clinical evidence and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Oral lidocaine for reflux or mucositis: clinical evidence and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Prevention and management of violence in long-term care: clinical evidence and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) High-sensitivity cardiac troponin for the rapid diagnosis of acute coronary syndrome in the emergency department
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Components and materials used for total hip replacement: a review of the comparative clinical effectiveness
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Knee implant systems: a review of the comparative clinical effectiveness
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Intramuscular oxytocin for the prevention of post-partum hemorrhage outside the hospital: clinical evidence and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Warming of amniofluid: safety
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Point of care testing compared to laboratory testing for the assessment of white blood cell counts and differentials: a review of the clinical effectiveness, diagnostic precision and accuracy, cost-effectiveness, and guidelines
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) Frequency of blood pressure measurements for children and adults: evidence-based guidelines
2013 Health Council of the Netherlands Gezondheidsraad (GR) Population Screening Act: mammography in two directions as standard
2013 Health Council of the Netherlands Gezondheidsraad (GR) Population Screening Act: calcium score and the risk of cardiovascular disease
2013 Health Council of the Netherlands Gezondheidsraad (GR) Population Screening Act: national population screening programme for bowel cancer
2013 Health Council of the Netherlands Gezondheidsraad (GR) Population Screening Act: Continuing a population screening trial
2013 Health Council of the Netherlands Gezondheidsraad (GR) The individual, collective and public importance of vaccination
2013 Health Council of the Netherlands Gezondheidsraad (GR) Vaccination of infants against pneumococcal infections (3)
2013 Health Council of the Netherlands Gezondheidsraad (GR) Population Screening Act: bowel cancer screening by pill camera
2013 Health Council of the Netherlands Gezondheidsraad (GR) NIPT: dynamics and ethics of prenatal screening
2013 Health Council of the Netherlands Gezondheidsraad (GR) Population Screening Act: noninvasive prenatal test for increased risk of trisomy
2013 The Swedish Council on Health Technology Assessment (SBU) [Occupational exposures and sleep disturbances]
2013 Andalusian Health Technology Assessment Area (AETSA) [Treatments for localized prostate cancer: Radical prostatectomy versus brachytherapy. Systematic review of the literature and case series]
2013 Andalusian Health Technology Assessment Area (AETSA) [Efficiency of peritoneal dialysis versus hemodialysis for the treatment of renal insufficiency]
2013 Andalusian Health Technology Assessment Area (AETSA) [Esteem® totally implantable hearing device for treatment of sensorineural hearing loss. Systematic review]
2013 Andalusian Health Technology Assessment Area (AETSA) [Effectiveness of computer-aided diagnosis applied to breast cancer screening. Systematic review]
2013 Andalusian Health Technology Assessment Area (AETSA) [Efficacy and safety of the Solitaire® flow restoration blood device]
2013 Andalusian Health Technology Assessment Area (AETSA) [Safety of natural therapies with direct impact on health: Acupuncture]
2013 Andalusian Health Technology Assessment Area (AETSA) [Efficacy, effectivity and efficiency of liquid cytology for cervical cancer screening and HPV infection diagnosis]
2013 Andalusian Health Technology Assessment Area (AETSA) [Effectiveness of patient self-testing and patient self-management of oral anticoagulation with vitamin K antagonists]
2013 Health Quality Ontario (HQO) Electrocardiograms for diagnosing ischemia as a precipitant to acute heart failure: a rapid review
2013 Health Quality Ontario (HQO) Relationship of patient volume and stroke outcomes: a rapid review
2013 Health Quality Ontario (HQO) Action plans for individuals with chronic obstructive pulmonary disease (COPD): a rapid review
2013 Health Quality Ontario (HQO) Inhospital physiotherapy for acute exacerbations of chronic obstructive pulmonary disease (AECOPD): a rapid review
2013 Health Quality Ontario (HQO) B-type natriuretic peptide testing: a rapid review
2013 Health Quality Ontario (HQO) Chest X-rays for diagnosing pulmonary infection as a precipitant of acute heart failure: a rapid review
2013 Health Quality Ontario (HQO) Effectiveness and safety of thrombolytics for the treatment of ischemic stroke: a rapid review
2013 Health Quality Ontario (HQO) Transient ischemic attack: where can patients receive optimal care? A rapid review
2013 Health Quality Ontario (HQO) Vasodilators for inhospital heart failure management: a rapid review
2013 Health Quality Ontario (HQO) Optimized timing of thrombolytic therapy for the treatment of stroke: a rapid review
2013 Health Quality Ontario (HQO) Early mobilization and ambulation in hospitalized heart failure patients:a rapid review